Slavka Hamulakova (Slávka Hamuľaková)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Aqueous Solution

Subarachnoid Hemorrhage

Cerebral Blood Flow

Anti Inflammatory

Top Venues

Future medicinal chemistry

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Adrián Gucký, Slavka Hamulakova
Targeting Biometals in Alzheimer's Disease with Metal Chelating Agents Including Coumarin Derivatives. CNS drugs (2024)
Adrián Gucký, Slavka Hamulakova
Targeting Biometals in Alzheimer's Disease with Metal Chelating Agents Including Coumarin Derivatives. CNS drugs 38 (7) (2024)
Adrián Gucký, Slavka Hamulakova
Targeting Biometals in Alzheimer's Disease with Metal Chelating Agents Including Coumarin Derivatives. CNS drugs 38 (7) (2024)
Adrián Gucký, Slavka Hamulakova
Targeting Biometals in Alzheimer's Disease with Metal Chelating Agents Including Coumarin Derivatives. CNS drugs 38 (7) (2024)
Monika Hudáčová, Slavka Hamulakova, Eva Žilecká, Rastislav Jendzelovsky, Jana Vargová, Juraj Ševc, Peter Fedoročko, Ondrej Soukup, Jana Janočková, Veronika Ihnatova, Tomas Kucera, Petr Bzonek, Nikola Novakova, Daniel Jun, Lucie Junova, Jan Korabecny, Teodorico C Ramalho, Maria Kozurkova
Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells. International journal of molecular sciences 22 (8) (2021)
Slavka Hamulakova, Zuzana Kudlickova, Ladislav Janovec, Roman Mezencev, Zachery J Deckner, Yury O Chernoff, Jana Janockova, Veronika Ihnatova, Petr Bzonek, Nikola Novakova, Vendula Hepnarova, Martina Hrabinova, Daniel Jun, Jan Korabecny, Ondrej Soukup, Teodorico C Ramalho
Design and synthesis of novel tacrine-indole hybrids as potential multitarget-directed ligands for the treatment of Alzheimer's disease. Future medicinal chemistry 13 (9) (2021)